The Middle EAST Adeno Associated Virus Vector Manufacturing Market was valued at USD 0.45 billion in 2024 and is projected to reach USD 1.20 billion by 2034, registering a CAGR of 10.0%. This growth trajectory is underpinned by several factors, including the increasing prevalence of genetic disorders, rising investments in gene therapy research, and the growing demand for advanced therapeutic...